Related Experiment Video

Updated: Jun 23, 2026

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
08:56

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions

Published on: November 30, 2022

New approach to incorporation of boron in tumor-seeking molecules

I B Sivaev1, A A Semioshkin, V I Bregadze

  • 1A.N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, 28 Vavilov Street, 119991 Moscow, Russia. sivaev@ineos.ac.ru

Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine
|April 21, 2009
PubMed

Insights

Cyclic oxonium derivatives of boron hydrides show promise for modifying tumor-targeting molecules. These compounds are excellent starting points for developing boron neutron capture therapy (BNCT) agents.

Area of Science:

  • Inorganic Chemistry
  • Medicinal Chemistry
  • Materials Science

Background:

  • Polyhedral boron hydrides are versatile scaffolds in chemistry.
  • Boron neutron capture therapy (BNCT) is an emerging cancer treatment modality.
  • Targeted drug delivery requires specific biomolecule modification.

Purpose of the Study:

  • To explore cyclic oxonium derivatives of polyhedral boron hydrides.
  • To assess their potential for modifying tumor-seeking biomolecules.
  • To evaluate their utility as precursors for BNCT agents.

Main Methods:

  • Synthesis of novel cyclic oxonium derivatives.
  • Characterization of the synthesized compounds.
  • Exploration of conjugation strategies with biomolecules.

Main Results:

  • Novel cyclic oxonium derivatives were successfully synthesized.
  • These derivatives demonstrated potential for conjugation with biomolecules.
  • The compounds show promise as building blocks for BNCT agents.

Conclusions:

  • Cyclic oxonium derivatives of polyhedral boron hydrides are valuable synthetic precursors.
  • They offer a promising route for developing targeted BNCT agents.
  • Further research is warranted to fully realize their therapeutic potential.

More Related Videos

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model09:02

Nanoparticle Delivery of an Oligonucleotide Payload in a Glioblastoma Multiforme Animal Model

Published on: September 27, 2024

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Hydroboration-Oxidation of Alkenes03:08

Hydroboration-Oxidation of Alkenes

In addition to the oxymercuration–demercuration method, which converts the alkenes to alcohols with Markovnikov orientation, a complementary hydroboration-oxidation method yields the anti-Markovnikov product. The hydroboration reaction, discovered in 1959 by H.C. Brown, involves the addition of a B–H bond of borane to an alkene giving an organoborane intermediate. The oxidation of this intermediate with basic hydrogen peroxide forms an alcohol.